Cullinan Associates’s Illumina ILMN Stock Holding History

Cullinan Associates’s Portfolio ILMN Stock Details ILMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-925	Closed	-$330K	–	183
2018 Q3	$330K	Sell	925 -103	-10%	-$33K	0.02%	163
2018 Q2	$279K	Buy	+1,028	New	+$262K	0.02%	168

Other funds holding ILMN

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cullinan Associates's ILMN Position: Q4 2018 in Review

Cullinan Associates sold out of Illumina (ILMN) in Q4 2018, closing a stake of 925 shares — an estimated $330K sold.

Cullinan Associates first reported a position in ILMN in Q2 2018 and held it in 2 quarters. The position peaked at $330K in Q3 2018. 843 funds tracked by Wall St. Rank hold ILMN as of Q4 2018.

Cullinan Associates reported no remaining Illumina position as of Q4 2018 after selling out during the quarter.
Cullinan Associates sold 925 Illumina shares in Q4 2018, an estimated $330K.
Cullinan Associates first reported a position in Illumina in Q2 2018 and held it in 2 quarters.
Cullinan Associates's Illumina position peaked at $330K in Q3 2018.
843 funds tracked by Wall St. Rank held Illumina as of Q4 2018.

Based on Cullinan Associates's 13F filing for Q4 2018, filed 11 Jan 2019.